Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$1.76 USD
-0.04 (-2.22%)
Updated Jul 29, 2024 03:58 PM ET
After-Market: $1.79 +0.03 (1.70%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/1/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -1.29 |
Last EPS Surprise | -6.61% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.15 |
Next Year | -1.55 |
EPS (TTM) | -4.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 20.00M | 40.20M | 39.14M |
# of Estimates | NA | 1 | 1 | 1 |
High Estimate | NA | 20.00M | 40.20M | 39.14M |
Low Estimate | NA | 20.00M | 40.20M | 39.14M |
Year ago Sales | 0.53M | 0.01M | 2.05M | 40.20M |
Year over Year Growth Est. | NA | 199,900.00% | 1,860.02% | -2.64% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.42 | -3.15 | -1.55 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -1.26 | -0.46 | -2.53 | -1.80 |
High Estimate | 1.23 | 0.32 | -1.98 | -1.04 |
Low Estimate | -1.28 | -1.12 | -4.84 | -1.82 |
Year ago EPS | -1.09 | -1.04 | -4.18 | -3.15 |
Year over Year Growth Est. | 59.63% | 59.62% | 24.64% | 50.77% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.42 | -3.15 | -1.55 |
7 Days Ago | -0.44 | -0.42 | -3.15 | -1.55 |
30 Days Ago | -0.44 | -0.42 | -3.15 | -1.55 |
60 Days Ago | -0.44 | -0.42 | -3.15 | -1.55 |
90 Days Ago | -0.42 | -0.71 | -2.80 | -2.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.42 | -3.15 | -1.55 |
Zacks Consensus Estimate | -0.44 | -0.42 | -3.15 | -1.55 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.29 | -1.17 | -1.04 | -1.09 | NA |
Estimate | -1.21 | -1.18 | -1.10 | -1.06 | NA |
Difference | -0.08 | 0.01 | 0.06 | -0.03 | -0.01 |
Surprise | -6.61% | 0.85% | 5.45% | -2.83% | -0.79% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more